https://www.selleckchem.com/products/bb-94.html
Glucocorticoids (GC) remain integral to large vessel vasculitis (LVV) and ANCA-associated vasculitis (AAV) treatment. We aimed to assess real-world GC tapering trajectories among patients referred for LVV or AAV and identify factors associated with 'delayed' tapering. Patients first assessed at a vasculitis clinic July 2017-August 2019 for LVV or AAV and taking GC were included. Delayed tapering was defined as prednisone 10 mg above target based on tapering recommendations (2010 British Society of Rheumatology Guidelines for Giant Cel
Like
Comment
Share
